Jessica Serra | Investor Relations |
Mark Foley | Chief Executive Officer |
Dustin Sjuts | President |
Toby Schilke | Chief Financial Officer |
Seamus Fernandez | Guggenheim |
Balaji Prasad | Barclays |
Chris Shibutani | Goldman Sachs |
Stacy Ku | Cowen |
David Amsellem | Piper Sandler |
Terence Flynn | Morgan Stanley |
Welcome to the Revance Therapeutics First Quarter 2023 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode.
Following managements’ prepared remarks, we will hold a Q&A Session. [Operator Instructions] As a reminder, this call is being recorded today, Tuesday, May 9, 2023. [Indiscernible]